Age of the company
11 yearsCapital in CHF
203'547Active brands
0Reports for Amyra Biotech AG
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out moreEconomic information
Comprehensive information about the economic situation of a company. Find out morePayment collection information
Overview of current and past debt enforcement proceedings. Find out moreCompany dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data. Retrieve company dossierAbout Amyra Biotech AG
- Amyra Biotech AG is currently active and the industry «Research and development». The legal headquarters are in Basel.
- The management of the company Amyra Biotech AG consists of 6 persons. The foundation of the company took place on 15.03.2013.
- Under «Notifications» you will find all commercial register changes, the most recent one was made on 06.07.2023.
- In the commercial register the company Amyra Biotech AG is registered under the UID CHE-321.956.288.
- On the same address there are 10 other active companies registered. These include: Allcon AG, Bests AG, BPP Business Promotion Partner AG in Liquidation.
Management (6)
newest board members
Douglas C. Günthardt,
Dr. Werner Tschollar,
Dr. Thomas Zehnder
newest authorized signatories
Julian Tschollar,
Sulayman Mourabit,
Douglas C. Günthardt,
Marcel Charles Gremaud,
Dr. Werner Tschollar
Commercial register information
Entry in the commercial register
15.03.2013
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Basel
Commercial Registry Office
BS
Commercial register number
CH-170.3.037.708-6
UID/VAT
CHE-321.956.288
Sector
Research and development
Purpose (Original language) Customise the company purpose with just a few clicks.
Forschung, Entwicklung, Fabrikation und Vertrieb im Bereich von pharmazeutischen, medizinischen, biotechnologischen und verwandten Produkten sowie Erbringung von damit im Zusammenhang stehenden Dienstleistungen; vollständige Zweckumschreibung gemäss Statuten.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young AG | Basel | 11.07.2017 | ||
Former auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Caminada Revisions AG | Zug | 23.12.2014 | 10.07.2017 | |
Other company names
Es sind keine früheren oder übersetzten Firmannamen vorhanden.
Would you like to update the company name? Click here.Ownership structure
Holdings
Newest SOGC notifications: Amyra Biotech AG
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1005788737, Commercial Registry Office Basel-Stadt, (270)
Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 112 vom 13.06.2023, Publ. 1005767195).
Statutenänderung:
27.06.2023. Die Gesellschaft hat mit Beschluss vom 27.06.2023 eine Erhöhung des bedingten Kapitals gemäss näherer Umschreibung in den Statuten beschlossen.
Publication number: HR02-1005767195, Commercial Registry Office Basel-Stadt, (270)
Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 122 vom 27.06.2022, Publ. 1005505277).
Ausgeschiedene Personen und erloschene Unterschriften:
Jelinski, Ralph, deutscher Staatsangehöriger, in Remigen, Vizedirektor, mit Kollektivunterschrift zu zweien.
Eingetragene Personen neu oder mutierend:
Mourabit, Sulayman, belgischer Staatsangehöriger, in Winterthur, mit Kollektivunterschrift zu zweien;
Tschollar, Julian, von Préverenges, in Préverenges, mit Kollektivunterschrift zu zweien.
Publication number: HR02-1005505277, Commercial Registry Office Basel-Stadt, (270)
Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 190 vom 30.09.2021, Publ. 1005302050).
Statutenänderung:
15.06.2022. Die Generalversammlung hat mit Beschluss vom 15.06.2022 genehmigtes Aktienkapital gemäss näherer Umschreibung in den Statuten geschaffen. [bisher: Die Generalversammlung hat mit Beschluss vom 29.06.2020 genehmigtes Aktienkapital gemäss näherer Umschreibung in den Statuten geschaffen.]
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.